Monday 12/14 Insider Buying Report: CCI (Nasdaq.com)
At Crown Castle International, a filing with the SEC revealed that on Thursday, Director J. Landis Martin bought 2,100 shares of CCI, for a cost of $157.28 each, for a total investment of $330,283. Martin was up about 1.0% on the purchase at the high point of today’s trading session, with CCI trading as high as $158.89 at last check today. Crown Castle International is trading up about 1.4% on the day Monday. Before this latest buy, Martin made one other purchase in the past year, buying $1.3M shares at a cost of $161.19 a piece.
Insider Trading: December 14, 2020 (BIV.com)
Insider Mark Anthony Miller, director. Company: Thunderbird Entertainment Group Inc. (TSX-V:TRBD). Shares owned: 1,000,000. Trade date: Dec 4. Trade total: $1,632,000. Trade: Sale of 600,000 shares at a price of $2.72 per share. Insider Bruce Linton, 10% owner. Company: Vireo Health International Inc. (CNSX:VREO). Shares owned: 1,114,115. Trade date: Dec 4. Trade total: $239,751. Trade: Sale of 156,700 shares at a price of $1.53 per share.
The Chief Financial Officer & Corporate Secretary of Platinum Group Metals (NYSE MKT: PLG) is Selling Shares (Analyst Ratings)
Today, the Chief Financial Officer & Corporate Secretary of Platinum Group Metals (PLG), Frank R Hallam, sold shares of PLG for $108.7K. Following Frank R Hallam’s last PLG Sell transaction on December 02, 2020, the stock climbed by 3.2%. In addition to Frank R Hallam, 4 other PLG executives reported Sell trades in the last month.
Elastic Nv (ESTC) CEO and Chairman Shay Banon Sold $50 million of Shares (Guru Focus)
CEO and Chairman of Elastic Nv, Shay Banon, sold 353,945 shares of ESTC on 12/10/2020 at an average price of $141.24 a share. The total sale was $50 million. Elastic NV has a market cap of $12.37 billion; its shares were traded at around $141.480000 with and P/S ratio of 23.13.
Notable Insider Buys Of the Past Week: Avis Budget, Biotech IPOs And More (Benzinga)
In the past week, a couple of officers and some directors bought some Silverback Therapeutics Inc (SBTX) shares at the initial public offering price of $21.00 per share. The total for the more than 1.54 million shares of this clinical-stage biopharmaceutical company they acquired added up to almost $35.5 million. The shares ended the week changing hands at $31.80 apiece, after hitting a high of $32.91. Life sciences company Seer, Inc. (SEER) also went public, and two 10% owners and a director scooped up almost 1.76 million shares altogether at the IPO price of $19.00 per share. That added up to around $33.41 million. Shares of this Redwood City, California-based biotech ended last week’s trading all the way up at $75.65 per share, after hitting a high of $86.13 on Friday.
